Glucosio Con Potassio Cloruro Monico

Glucosio Con Potassio Cloruro Monico is an intravenous solution that combines potassium chloride and glucose monohydrate in a sterile liquid formulation. It is supplied as a ready‑to‑use IV electrolyte solution intended for infusion during treatment into the bloodstream. The product is manufactured for the European market and is available by prescription only. It provides potassium ions for electrolyte balance and glucose for energy and osmotic support.

Glucosio Con Potassio Cloruro Monico is used in clinical settings where potassium replacement and fluid resuscitation are required.

- Correction of hypokalemia (low blood potassium) in patients receiving diuretics, laxatives, or gastrointestinal losses. - Support of electrolyte balance during postoperative recovery or intensive care management. - Provision of an energy source and osmotic agent during intravenous fluid therapy. - Adjunct to blood transfusion or chemotherapy protocols to maintain plasma potassium levels. - Use in pediatric or neonatal care when precise potassium dosing is needed under medical supervision.

Potential adverse reactions to the intravenous solution are categorized by frequency and severity.

Common: - Mild irritation at the infusion site, such as erythema or discomfort. - Transient nausea or vomiting related to rapid infusion. - Mild hyperglycemia in patients with impaired glucose tolerance. - Temporary increase in serum potassium that resolves with monitoring.

Serious: - Severe hyperkalemia leading to cardiac arrhythmias. - Anaphylactic or severe allergic reaction, including bronchospasm or hypotension. - Local tissue necrosis if extravasation occurs.

Clinicians should observe specific precautions when prescribing Glucosio Con Potassio Cloruro Monico to minimize risks and ensure therapeutic effectiveness.

- Assess serum potassium and glucose levels before initiating therapy. - Adjust infusion rate in patients with renal impairment or heart failure. - Avoid rapid administration to reduce the risk of hyperkalemia. - Monitor cardiac rhythm continuously during high‑dose potassium infusion. - Use a compatible IV set and avoid mixing with calcium‑containing solutions. - Confirm correct patient identity and dosage calculations, especially in pediatric cases. - Document any adverse reactions promptly in the medical record.

The potassium‑chloride/glucose solution may interact with other medications, influencing electrolyte balance or infusion compatibility.

Avoid: - Concurrent administration of other potassium salts or potassium‑sparing diuretics without monitoring. - Co‑infusion with calcium gluconate or calcium chloride, which can precipitate insoluble salts. - Mixing with alkaline solutions that may cause precipitation of potassium chloride.

Use with caution: - Concurrent use of insulin or glucose‑lowering agents, which may exacerbate hypoglycemia. - Renal replacement therapies such as dialysis, requiring dose adjustments. - Beta‑adrenergic agonists that shift potassium intracellularly, potentially masking serum levels. - Non‑steroidal anti‑inflammatory drugs (NSAIDs) that may affect renal potassium handling.